TwinBeech Capital’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,500
Closed -$1.59M 634
2026
Q1
$1.59M Buy
+13,500
New +$1.89M 0.16% 177
2025
Q3
Sell
-94,388
Closed -$11.7M 788
2025
Q2
$11.7M Buy
+94,388
New +$12M 0.27% 105
2024
Q2
Sell
-10,379
Closed -$1.91M 754
2024
Q1
$1.91M Buy
+10,379
New +$1.98M 0.04% 347
2023
Q3
Sell
-11,144
Closed -$1.58M 854
2023
Q2
$1.58M Buy
+11,144
New +$1.79M 0.03% 404
2022
Q4
Sell
-49,554
Closed -$9.27M 899
2022
Q3
$9.27M Buy
+49,554
New +$10.4M 0.24% 120
2020
Q4
Sell
-7,577
Closed -$1.12M 580
2020
Q3
$1.12M Buy
+7,577
New +$1.08M 0.24% 128

Other funds holding RGEN

TwinBeech Capital's RGEN Position: Q2 2026 in Review

TwinBeech Capital sold out of Repligen (RGEN) in Q2 2026, closing a stake of 13,500 shares — an estimated $1.59M sold.

TwinBeech Capital first reported a position in RGEN in Q3 2020 and held it in 6 quarters. The position peaked at $11.7M in Q2 2025. 478 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • TwinBeech Capital reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • TwinBeech Capital sold 13,500 Repligen shares in Q2 2026, an estimated $1.59M.
  • TwinBeech Capital first reported a position in Repligen in Q3 2020 and held it in 6 quarters.
  • TwinBeech Capital's Repligen position peaked at $11.7M in Q2 2025.
  • 478 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.